C. Jommi, F. Cipriani, F. Fanelli, M. P. Pedone, and W. Canonica, “The effects of disease cross-coverage by dupilumab on the costs sustained by the Italian National Health Service”, Grhta, vol. 7, no. 1, pp. 33–39, Jul. 2020.